Cormedix Inc (CRMD)
9.59
-0.40
(-4.00%)
USD |
NASDAQ |
Nov 04, 16:00
9.40
-0.19
(-1.98%)
After-Hours: 20:00
Cormedix Net Income (Quarterly): -2.777M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -2.777M |
| June 30, 2024 | -14.15M |
| March 31, 2024 | -14.47M |
| December 31, 2023 | -14.75M |
| September 30, 2023 | -9.744M |
| June 30, 2023 | -11.27M |
| March 31, 2023 | -10.57M |
| December 31, 2022 | -8.209M |
| September 30, 2022 | -6.854M |
| June 30, 2022 | -7.605M |
| March 31, 2022 | -7.034M |
| December 31, 2021 | -7.791M |
| September 30, 2021 | -8.569M |
| June 30, 2021 | -4.633M |
| March 31, 2021 | -7.217M |
| December 31, 2020 | -6.087M |
| September 30, 2020 | -6.601M |
| June 30, 2020 | -3.782M |
| March 31, 2020 | -5.558M |
| December 31, 2019 | -5.304M |
| September 30, 2019 | -5.265M |
| June 30, 2019 | -0.6962M |
| March 31, 2019 | -5.168M |
| December 31, 2018 | 2.148M |
| September 30, 2018 | -10.24M |
| Date | Value |
|---|---|
| June 30, 2018 | -8.557M |
| March 31, 2018 | -10.19M |
| December 31, 2017 | -10.31M |
| September 30, 2017 | -9.956M |
| June 30, 2017 | -5.146M |
| March 31, 2017 | -7.597M |
| December 31, 2016 | -6.399M |
| September 30, 2016 | -9.126M |
| June 30, 2016 | -4.887M |
| March 31, 2016 | -4.118M |
| December 31, 2015 | -3.866M |
| September 30, 2015 | -4.688M |
| June 30, 2015 | -4.135M |
| March 31, 2015 | -5.498M |
| December 31, 2014 | -2.214M |
| September 30, 2014 | -5.035M |
| June 30, 2014 | 3.509M |
| March 31, 2014 | -16.71M |
| December 31, 2013 | -3.435M |
| September 30, 2013 | -2.500M |
| June 30, 2013 | -1.951M |
| March 31, 2013 | -1.247M |
| December 31, 2012 | -0.8519M |
| September 30, 2012 | -1.017M |
| June 30, 2012 | -0.613M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-14.75M
Minimum
Dec 2023
-2.777M
Maximum
Sep 2024
-8.149M
Average
-7.411M
Median
Net Income (Quarterly) Benchmarks
| Imunon Inc | -4.788M |
| Rockwell Medical Inc | 0.343M |
| Brainstorm Cell Therapeutics Inc | -2.541M |
| Outlook Therapeutics Inc | 44.41M |
| Aquestive Therapeutics Inc | -2.745M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 11.46M |
| Total Expenses (Quarterly) | 14.74M |
| EPS Diluted (Quarterly) | -0.05 |
| Enterprise Value | 535.86M |
| Gross Profit Margin (Quarterly) | 94.01% |
| Profit Margin (Quarterly) | -24.24% |
| Earnings Yield | -8.45% |
| Normalized Earnings Yield | -8.440 |